Tag

Shares in Novo Nordisk rose as much as 5 percent on Monday after the U.S. Food and Drug Administration (FDA) approved the diabetes drug Tresiba, allowing the Danish drugmaker to prepare its largest ever drug launch.

The U.S. Food and Drug Administration has approved two diabetes drugs from Danish drugmaker Novo Nordisk.